Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: Analysis of Grade 5 radiation pneumonitis

Journal of Radiation Research

Volumn 55, Issue 3, 2014, Pages 575-582

  Aibe, Norihiro ^a,b   Yamazaki, Hideya ^a,b   Nakamura, Satoaki ^a,b   Tsubokura, Takuji ^a   Kobayashi, Kana ^a   Kodani, Naohiro ^a   Nishimura, Takuya ^b   Okabe, Haruumi ^b   Yamada, Kei ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Ujitakeda Hospital   (Japan)

Author keywords

helical tomotherapy; lung cancer; SBRT; severe radiation pneumonitis

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; RADIATION; RADIOTHERAPY; TUMORS;

CAUSE-SPECIFIC SURVIVAL; HELICAL TOMOTHERAPY; LOCAL CONTROL; LUNG CANCER; LUNG TUMOR; MEDICAL RECORD; RADIATION PNEUMONITIS; SBRT; SEVERE RADIATION PNEUMONITI; STEREOTACTIC BODY RADIOTHERAPY;

TOXICITY;

AGED; CLASSIFICATION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; JAPAN; LUNG NEOPLASMS; LUNG RESECTION; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIATION PNEUMONIA; RADIOSURGERY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSALITY; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84900875205     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt146     Document Type: Article

References (23)

1. Videtic GM, Stephans KL. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 2010; 12: 235-41.
2. Chi A, Liao Z, Nguyen NP et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010; 94: 1-11.
3. Welsh JS, Patel RR, Ritter MA et al. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat 2002; 1: 311-6.
4. Hodge W, Tome WA, Jaradat HA et al. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol 2006; 45: 890-6.
5. Klein M, Gaede S, Yartsev S. A study of longitudinal tumor motion in helical tomotherapy using a cylindrical phantom. J Appl Clin Med Phys 2013; 14: 4022.
6. Kanagaki B, Read PW, Molloy JA et al. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion. Phys Med Biol 2007; 52: 243-55.
7. Kissick MW, Flynn RT, Westerly DC et al. On the impact of longitudinal breathing motion randomness for tomotherapy delivery. Phys Med Biol 2008; 53: 4855-73.
8. Baisden JM, Romney DA, Reish AG et al. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. Int J Radiat Oncol Biol Phys 2007; 68: 1229-37.
9. Tomita N, Kodaira T, Matsuo M et al. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans. Technol Cancer Res Treat 2010; 9: 407-15.
10. Chi A, Jang SY, Welsh JS et al. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage nonsmall-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys 2011; 81: 856-62.
11. Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-9.
12. RTOG 0236 Protocol Information. A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. http: //www.rtog.org/ClinicalTrials/ ProtocolTable/StudyDetails. aspx?study=0236 (10 May 2013, date last accessed).
13. Shibamoto Y, Otsuka S, Iwata H et al. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model. J Radiat Res 2012; 53: 1-9.
14. Iwata H, Matsufuji N, Toshito T et al. Compatibility of the repairable-conditionally repairable, multi-target and linearquadratic models in converting hypofractionated radiation doses to single doses. J Radiat Res 2013; 54: 367-73.
15. Wada M, Suzuki M, Liu C et al. Modeling the biological response of normal human cells, including repair processes, to fractionated carbon beam irradiation. J Radiat Res 2013; 54: 798-807.
16. Yamashita H, Kobayashi-Shibata S, Terahara A et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 2010; 5: 32.
17. Takeda A, Sanuki N, Kunieda E et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys 2009; 73: 442-8.
18. Matsuo Y, Shibuya K, Nakamura M et al. Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2012; 83: e545-9.
19. Inoue T, Katoh N, Onimaru R et al. Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer. Radiat Oncol 2013; 8: 69.
20. Baker R, Han G, Sarangkasiri S et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys 2013; 85: 190-5.
21. Barriger RB, Forquer JA, Brabham JG et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010; 82: 457-62.
22. Takeda A, Kunieda E, Sanuki N et al. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys 2009; 74: 363-9.
23. Ong CL, Palma D, Verbakel WF et al. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity. Radiother Oncol 2010; 97: 431-6.